PATENT CLAIM ANALYSIS

Application Number: 16342083
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "129000"]

Abstract:
The present disclosure relates to the design and development of new hydroxycinnamic derivatives that operate as mitochondriotropic antioxidants. Furthermore, this disclosure is also related to the methods and uses of the hydroxycinnamic derivatives, for example, in the field of human and animal diseases, for instance to treat mitochondrial dysfunction or mitochondrial deficiencies, and cosmetics, for instance to prevent or delay skin aging.

Claim (Index 13):
The compound according to  claim 1  wherein R 2  and R 3  are OH.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 100.0
- Lexical Diversity: 1.55556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10568655', '10568654', '15037941', '14416529', '11172916']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7456241521588096
- 35 USC 102 Novelty (BERT): 0.5251320345510279
- Combined Prediction Score: 0.7235749403980315
- Mean Citation Score: 235.96666
- Max Citation Score: 250.70346
- Similarity Product: 138.60082708881498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test